Trade PLRX anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Pliant Therapeutics, Inc. (PLRX) is trading at US$1.11, down 3.48% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$71.52M. Over the past 52 weeks, PLRX has traded between US$1.02 and US$1.95. On Syfe you can trade PLRX with $0 commission and add it to your watchlist.
| Previous close | US$1.15 |
|---|---|
| Market cap | US$71.52M |
| 52-week range | US$1.02 – US$1.95 |
| Volume | 233.14K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Pliant Therapeutics, Inc.
Pliant Therapeutics, Inc. engages in the discovery, development and commercialization of therapies for fibrotic diseases. It offers a product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-ß1 signaling inhibition. The company was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.
Year: 2020
Pliant Therapeutics, Inc. (PLRX) stock is trading at US$1.11, -3.48% from the previous close of US$1.15.
The market cap for Pliant Therapeutics, Inc. (PLRX) stock is approximately US$71.52M.
The 52-week high for Pliant Therapeutics, Inc. (PLRX) stock is US$1.95.
The 52-week low for Pliant Therapeutics, Inc. (PLRX) stock is US$1.02.
Pliant Therapeutics, Inc. (PLRX) does not currently pay a dividend.
Stay on top of PLRX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
